ticlopidine has been researched along with Retroperitoneal Neoplasms in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Retroperitoneal Neoplasms: New abnormal growth of tissue in the RETROPERITONEAL SPACE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernandez-Pineda, I | 1 |
| Lopez-Gutierrez, JC | 1 |
| Chocarro, G | 1 |
| Bernabeu-Wittel, J | 1 |
| Ramirez-Villar, GL | 1 |
1 trial available for ticlopidine and Retroperitoneal Neoplasms
| Article | Year |
|---|---|
Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aspirin; Child, Preschool; Ecchymosis; Female; Follo | 2013 |